A Dose Ranging Study to Examine TDS-Testosterone 5%
NCT: NCT01894308 · NOT_YET_RECRUITING
Brief Summary
This study is a continuation of previous studies done in healthy volunteers to prove the efficacy of delivering Testosterone, the male hormone, rapidly across intact skin in s series of doses from low to high in men with low-to-no natural testosterone production to measure their response to the varying doses. The results of this study will inform further studies which will be longer in length, as to the starting doses. The study will be conducted in London, U.K. at the Advanced Therapies Centre, The London Clinic.
Frequently Asked Questions
What is A Dose Ranging Study to Examine TDS-Testosterone 5%?
A Dose Ranging Study to Examine TDS-Testosterone 5% is a clinical trial registered under NCT01894308. Current status: NOT_YET_RECRUITING.
What is the status of NCT01894308?
The current status of NCT01894308 (A Dose Ranging Study to Examine TDS-Testosterone 5%) is: NOT_YET_RECRUITING.
When did A Dose Ranging Study to Examine TDS-Testosterone 5% start?
A Dose Ranging Study to Examine TDS-Testosterone 5% started on 2027-06.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.